UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$456M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$403M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$391M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$381M |
| 5 |
UnitedHealth
UNH
|
+$355M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$596M |
| 4 |
Johnson & Johnson
JNJ
|
+$307M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.25% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.58% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
Tronox
TROX
$993M
| $987K | ﹤0.01% |
77,690
+15,791
| +26% | +$199K |
|
4252
International Money Express
IMXI
$356M
| $987K | ﹤0.01% |
40,217
+9,485
| +31% | +$233K |
|
4253
AutoNation
AN
$6.88B
| $986K | ﹤0.01% |
5,992
-5,796
| -49% | -$804K |
|
4254
CALL
Regenxbio
RGNX
$688M
| $986K | ﹤0.01% |
+49,300
| New | +$950K |
|
|
4255
PUT
Regenxbio
RGNX
$688M
| $986K | ﹤0.01% |
+49,300
| New | +$950K |
|
4256
ICU Medical
ICUI
$4.56B
| $984K | ﹤0.01% |
5,523
-10,563
| -66% | -$1.94M |
|
4257
Opendoor
OPEN
$3.38B
| $983K | ﹤0.01% |
252,658
+137,973
| +120% | +$299K |
|
|
TRUE
4258
DELISTED
TrueCar
TRUE
| $983K | ﹤0.01% |
434,921
+403,573
| +1,287% | +$961K |
|
4259
Zeta Global
ZETA
$6.91B
| $983K | ﹤0.01% |
115,083
+76,452
| +198% | +$699K |
|
4260
Pacer Industrial Real Estate ETF
INDS
$115M
| $983K | ﹤0.01% |
25,111
-1,173
| -4% | -$46.8K |
|
4261
Funko
FNKO
$347M
| $982K | ﹤0.01% |
90,773
+76,595
| +540% | +$843K |
|
|
PCK
4262
DELISTED
Pimco California Municipal Income Fund II
PCK
| $982K | ﹤0.01% |
165,061
-12,082
| -7% | -$72.8K |
|
|
MPV
4263
Barings Participation Investors
MPV
$176M
| $981K | ﹤0.01% |
76,010
+3,177
| +4% | +$40.1K |
|
4264
Conduent
CNDT
$242M
| $980K | ﹤0.01% |
288,323
-354,669
| -55% | -$1.16M |
|
4265
Cullinan Oncology
CGEM
$1.18B
| $980K | ﹤0.01% |
91,067
-9,985
| -10% | -$106K |
|
4266
VanEck Pharmaceutical ETF
PPH
$1B
| $980K | ﹤0.01% |
12,438
-1,636
| -12% | -$128K |
|
4267
Compañía de Cervecerías Unidas
CCU
$2.24B
| $980K | ﹤0.01% |
60,361
-1,498
| -2% | -$23.9K |
|
4268
LegalZoom.com
LZ
$973M
| $980K | ﹤0.01% |
81,094
+50,143
| +162% | +$530K |
|
4269
Orion
OEC
$389M
| $979K | ﹤0.01% |
46,141
+21,468
| +87% | +$517K |
|
4270
State Street SPDR S&P Pharmaceuticals ETF
XPH
$512M
| $979K | ﹤0.01% |
23,873
-687
| -3% | -$28.4K |
|
4271
Opko Health
OPK
$1.04B
| $978K | ﹤0.01% |
450,464
+140,294
| +45% | +$219K |
|
|
DNB
4272
DELISTED
Dun & Bradstreet
DNB
| $977K | ﹤0.01% |
84,482
+70,167
| +490% | +$763K |
|
4273
Pacira BioSciences
PCRX
$974M
| $977K | ﹤0.01% |
24,374
-5,177
| -18% | -$214K |
|
4274
Cogent Biosciences
COGT
$7.1B
| $977K | ﹤0.01% |
82,475
-10,475
| -11% | -$120K |
|
4275
Viasat
VSAT
$11.7B
| $976K | ﹤0.01% |
23,656
-328
| -1% | -$12.8K |
|
Similar funds
UBS Group's Q2 2023 Portfolio in Review
As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
- UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
- UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
- UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
- UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
- UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.